Endostatin and angiostatin: The next anti-angiogenesis generation

Angiogenesis

Volumn 2, Issue 1, 1998, Pages 25-27

  Kohn, Elise C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2342539925     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009046208807     Document Type: Short Survey

References (10)

1. O'Reilly MS, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 1996; 2, 689-692.
2. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88, 277-285.
3. Folkman J. Angiogenesis and angiogenesis inhibition: an overview. EXS 1997; 79, 1-8.
4. Folkman J. Angiogenesis inhibitors generated by tumors. Mol Med 1995; 1, 120-122.
5. Boehm T, Folkman J, Browder T, O'Reilly MS. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997; 390, 404-407.
6. Folkman J, Hochberg M, Knighton D. Self-regulation of growth in three dimensions: the role of surface area limitations. In: Clarkson, B Baserga R (eds), Control of Proliferation in Animal Cells. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press 1974: 833-842.
7. Folkman J. Fighting cancer by attacking its blood supply. Sci Am 1996; 150-154.
8. Kohn EC, Liotta LA. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 1995; 55, 1856-1862.
9. Liotta LA, Steeg PS. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation Cell 1991; 64, 327.
10. Liotta LA, Kleinerman J, Saidel G. Quantitative relationships of intravascular tumor cells: tumor vessels and pulmonary metastases following tumor implantation. Cancer Res 1974; 34, 997-1003.